###begin article-title 0
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
Evaluation of MFRP as a candidate gene for high hyperopia
###end article-title 0
###begin p 1
Dr. Wang and Dr. Yang contributed equally to this work.
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 220 224 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 92 100 <span type="species:ncbi:9606">patients</span>
Mutations in the membrane-type frizzled-related protein (MFRP) gene have been identified in patients with pathologic high hyperopia associated with nanophthalmos or microphthalmia. This study is to test if a mutation in MFRP is responsible for physiologic high hyperopia.
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 281 285 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
DNA was prepared from venous leukocytes of 51 patients with physiologic high hyperopia (refraction of spherical equivalent >/=+5.00 [diopters] D) and 96 controls (refraction of spherical equivalent between -0.50 D and +1.00 D). The coding regions and adjacent intronic sequence of MFRP were amplified by polymerase chain reaction (PCR) and were then analyzed by cycle sequencing. Variations detected were further evaluated in normal controls and available family members by heteroduplex- single-strand conformation polymorphism (SSCP) analysis or sequencing.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 203 207 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 42 50 <span type="species:ncbi:9606">patients</span>
The average spherical refractive error of patients was +8.41 D in the right eye (from +6.00 D to +16.5 D) and was +8.76 D in the left eye (from +6.00 D to +16.5 D). Five novel heterozygous variations in MFRP, c.55-14_55-13insGTAT, c.496C>G, c.664C>A, c.669G>A, and c.770G>A, were identified. Of these, c.664C>A (p.Pro222Thr) and c.669G>A (p.=) were not observed in the 96 normal controls. In addition, one known c.192C>G substitution and five single nucleotide polymorphisms (SNPs; , , , , and ) were detected.
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
Several novel variations in MFRP were detected in Chinese. Our results imply that MFRP is less likely to play a major role in physiologic high hyperopia.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 435 436 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 842 843 842 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 1157 1158 1157 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 1159 1160 1159 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 1290 1292 1290 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 1293 1295 1293 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 1435 1437 1435 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 1438 1440 1438 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1456 1460 1456 1460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 1633 1634 1633 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 1635 1636 1635 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 1637 1639 1637 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 1673 1677 1673 1677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 1749 1753 1749 1753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 1840 1842 1840 1842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 97 105 <span type="species:ncbi:9606">children</span>
###xml 439 447 <span type="species:ncbi:9606">Patients</span>
Hyperopia, alternatively termed hypermetropia or farsightedness, is a common refractive error in children and adults [1-3]. Hyperopia may be classified as low hyperopia (+2.00 diopters [D] or less), moderate hyperopia (between +2.25 D and +5.00 D), and high hyperopia (over +5.00 D) [4]. The prevalence of hyperopia (+3 D or higher) in adults is 9.9%, 11.6%, and 5.8% in the USA, Western European nations, and Australia, respectively [5]. Patients with high hyperopia may suffer from blurred vision, asthenopia, accommodative dysfunction, binocular dysfunction, amblyopia, strabismus, closure angle glaucoma, and retinal detachment. The morphological characteristics of high hyperopia include a short eye axis, a narrow angle between the cornea and iris, expansion of the choroidal vascular bed, and a thickening of sclera connective tissue [6]. Most cases of high hyperopia are physiologic high hyperopia that is not associated with other ocular or systemic anomalies. However, pathologic high hyperopia may present as a part of other eye abnormalities such as nanophthalmos, microphthalmia, anterior segment malformations, and Leber congenital amaurosis [7-9] while there are also numbers of high hyperopia associated with systemic syndromes such as Down syndrome and fragile X syndrome [10,11]. Compared with myopia, hereditary factors may play a more important role than environmental factors in the development of high hyperopia [12,13]. Mutations in MFRP have been identified to be responsible for nanophthalmos 2 (NNO2, OMIM ) and microphthalmia (OMIM ), where extremely high hyperopia (+8.00 D-+25.00 D) is a prominent sign [6,8,14]. However, whether variations in MFRP play any role in physiologic high hyperopia is still unclear, although MFRP in 11 individuals with hyperopia (4 of the 11 with high hyperopia) has been analyzed [14].
###end p 12
###begin p 13
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 497 498 497 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 1001 1005 1001 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mfrp</italic>
###xml 1064 1066 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 1067 1069 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 1095 1099 1095 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 1149 1150 1149 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 1342 1344 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1345 1347 1345 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 1489 1491 1489 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 1494 1498 1494 1498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 1057 1062 <span type="species:ncbi:10090">mouse</span>
###xml 1122 1128 <span type="species:ncbi:9606">humans</span>
The membrane-type frizzled related protein gene (MFRP; OMIM ), located in 11q23, is comprised of 13 exons, which translate into a 579 amino acid protein. Selectively expressed in the retinal pigment epithelium and the ciliary body with C1q and tumor necrosis factor related protein 5 (CTRP5) [6,15], the protein contains three domains, a cysteine-rich domain (CRD) at the COOH-terminus, a type II transmembrane domain, and an extracellular region with two tandem-repeats of cubilin (CUB) at the NH2-terminus [16]. The CRD can bind with Wnts (wingless type proteins), which belong to a family of cell signaling molecules that are possibly involved in eye development through mediating cell growth [17]. Additionally, CUB is homologous with the low density lipoprotein (LDL) receptor. Normal function of MFRP is essential for the eye to reach its full size at birth and is necessary for emmetropization, which is associated with the regulation of ocular axial growth [18]. Although a splice mutation of Mfrp causes a recessive retinal degeneration in the rd6 mouse [19,20], recessive mutations of MFRP have been detected in humans with nanophthalmos [8] and have been reported to be associated with an autosomal recessive ophthalmic syndrome characterized by posterior microphthalmos, retinitis pigmentosa, foveoschisis, and optic disc drusen [21,22]. Since the simple hyperopia cases represent a less severe form of a short axial length that is similar to the delineation of nanophthalmos [18], MFRP may also be the etiological factor of simple high hyperopia. The identification of the causative or susceptibility genetic factors involved in simple high hyperopia will have clinical implications for both ophthalmology and optometry.
###end p 13
###begin p 14
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 38 46 <span type="species:ncbi:9606">patients</span>
Here, MFRP was analyzed in 51 Chinese patients with physiologic high hyperopia to determine whether MFRP plays a role in the development of high hyperopia.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and clinical data
###end title 16
###begin p 17
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 983 991 <span type="species:ncbi:9606">patients</span>
A previously established and published procedure was used for collecting subjects and obtaining informed consent [23]. This study followed the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of Zhongshan Ophthalmic Center (Guangzhou, China). Chinese subjects with high hyperopia who met the following criteria were recruited: 1) they had bilateral refraction errors of +5.00 D or higher (spherical equivalent) and 2) they had no other known ocular or systemic diseases. A group of 96 controls met the following criteria: 1) bilateral refraction between -0.50 D and +1.00 D and 2) no family history of hyperopia. The refractive error for all eyes was measured with cycloplegic autorefraction after mydriasis (Mydrin(R)-P, a compound tropicamide; Santen Pharmaceutical Co. Ltd., Osaka, Japan). Ophthalmologic examinations were performed by ophthalmologists (Z.Y., Q.Z., and X.G.). Genomic DNA was prepared from the venous blood of 51 unrelated patients with high hyperopia and of the 96 normal controls.
###end p 17
###begin title 18
Variation analysis
###end title 18
###begin p 19
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 172 179 172 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 540 544 540 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 923 927 923 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 1030 1032 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 1193 1200 1193 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 108 113 <span type="species:ncbi:9606">human</span>
###xml 262 269 <span type="species:ncbi:9606">patient</span>
###xml 520 528 <span type="species:ncbi:9606">patients</span>
###xml 575 580 <span type="species:ncbi:9606">human</span>
Eight pairs of primers were used to amplify the 13 coding exons and the adjacent intronic sequence of MFRP (human genome build 36.2  for gDNA,  for cDNA, and  for protein; Table 1). The polymerase chain reaction (PCR) products for the individual exons from each patient were sequenced with the ABI BigDye Terminator cycle sequencing kit version 3.1 (Applied Biosystems, Foster City, CA) according to the manufacturer's recommendations using an ABI 3100 Genetic Analyzer (Applied Biosystems). Sequencing results from the patients as well as MFRP consensus sequences from the  human genome database () were imported into the SeqManII program of the Lasergene package (DNASTAR Inc., Madison, Wisconsin) and aligned to identify variations. Each variation was confirmed by bidirectional sequencing. The nomenclature of the variation was performed according to the directions recommended by the . Any detected novel variation in MFRP was further evaluated by either heteroduplex-SSCP (single-strand conformation polymorphism) analysis [24] or by direct sequencing in available family members as well as in the 96 normal controls. Extra pairs of primers were designed for heteroduplex-SSCP analysis (Table 2). Five variations (, , c.55-14_55-13insGTAT, c.496C>G, and c.770G>A) were genotyped and tested for association using Fisher's exact test with a significance level threshold of 0.05.
###end p 19
###begin title 20
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
Primers used for polymerase chain reaction amplification and sequencing of MFRP.
###end title 20
###begin p 21
GC buffer was provided by Takara Biotechnology (Dalian) CO.Ltd (Liaoning,China) and designed for amplification of templates having complex secondary structure or high GC content. In the "Primer sequence" column, "F" indicates the forward sequence and "R" indicates the reverse sequence.
###end p 21
###begin title 22
Primers used for evaluating the variations by heteroduplex-single strand conformational polymorphism analysis.
###end title 22
###begin p 23
In the "Primer sequence" column, "F" indicates the forward sequence and "R" indicates the reverse sequence.
###end p 23
###begin title 24
Results
###end title 24
###begin p 25
###xml 309 313 309 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 428 435 428 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 440 449 440 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 587 596 587 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B</xref>
###xml 1075 1084 1075 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1C</xref>
###xml 1272 1274 1272 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 24 32 <span type="species:ncbi:9606">patients</span>
###xml 126 134 <span type="species:ncbi:9606">patients</span>
###xml 679 686 <span type="species:ncbi:9606">patient</span>
###xml 1143 1151 <span type="species:ncbi:9606">patients</span>
A total of 51 unrelated patients with high hyperopia were recruited into our study. The average spherical refractive error of patients was +8.41 diopters in the right eye (from +6.00 D to +16.5 D) and was +8.76D in left eye (form +6.00D to +16.5 D). Direct sequencing identified 11 heterozygous variations in MFRP where the following five variations were novel: c.55-14_55-13insGTAT, c.496C>G, c.664C>A, c.669G>A, and c.770G>A (Table 3 and Figure 1A). Except for c.664C>A and c.669G>A, the rest of the novel variations were observed in the normal controls by heteroduplex-SSCP analysis (Figure 1B). For the missense variation, c.664C>A (p.Pro222Thr), which was identified in one patient, the threonine (a small, hydrophobic amino acid carrying charge) took the place of proline (a small amino acid), which resulted in a change at the protein level with a residue weight of -1 (evaluated by amino acid substitution matrices Blosum 62). The proline at position 222 is highly conserved for MFRP as demonstrated by an analysis of six orthologs from different vertebrate species (Figure 1C). For the synonymous variation, c.669G>A, observed in two patients, the substitution did not change the amino acid or transcript splicing. In addition, a reported substitution, c.192C>G [25], and five SNPs (, , , , and ) were observed. No statistical association was observed for variations (, , c.55-14_55-13insGTAT, c.496C>G, and c.770G>A) between high hyperopes and controls.
###end p 25
###begin title 26
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Sequence variations in MFRP observed in 51 patients with hyperopia.
###end title 26
###begin p 27
###xml 120 128 <span type="species:ncbi:9606">patients</span>
The novel variations are highlighted in bold. An asterisk indicates that no statistical difference was observed between patients and controls. ND: no detected.
###end p 27
###begin p 28
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 46 47 46 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 177 178 177 178 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 292 293 292 293 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
The five novel variations identified in MFRP. A: The sequences of variations (indicated by an arrow) are shown on the left to compare with the wild type sequences on the right. B: The variations, c.664C>A and c.669G>A, were not observed in normal controls (NC) by heteroduplex-SSCP analysis. C: The mutation, c.664C>A (indicated by an arrow), changed a highly conserved residue from proline to threonine.
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 371 375 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 478 482 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
###xml 384 392 <span type="species:ncbi:9606">patients</span>
###xml 543 551 <span type="species:ncbi:9606">patients</span>
###xml 662 670 <span type="species:ncbi:9606">patients</span>
Recently, MFRP was evaluated among 11 hyperopia patients. Five novel variations were identified, but direct sequencing and family-based association analysis of these variations did not implicate MFRP in the process of moderate to high hyperopia [14]. We screened this gene in a larger cohort of physiologic high hyperopia and identified five novel sequence variations of MFRP from 51 patients. Three of these (c.55-14_55-13insGTAT, c.496C>G, and c.770G>A) appeared to be common MFRP polymorphisms because all of them were screened not only in patients but also in normal controls. Two variations, c.664C>A (missense) and c.669G>A (silent), were detected in only patients with high hyperopia.
###end p 30
###begin p 31
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 488 492 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 518 522 518 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1161 1165 1161 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 1267 1271 1267 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 364 372 <span type="species:ncbi:9606">patients</span>
###xml 1074 1081 <span type="species:ncbi:9606">patient</span>
MFRP has already been screened in patients with different kinds of inherited eye diseases such as nanophthalmos 2 (NNO2, OMIM ) [26], posterior microphthalmia with retinitis pigmentosa, foveoschisis and optic disc drusen (OMIM ) [21,22], retinopathy [27], glaucoma [25,28], and ocular disease related to axial length [14]. Besides six MFRP mutations identified in patients with NNO2 or posterior microphthalmia with retinal degeneration, many non-pathological variations were observed in MFRP. Among the six causative MFRP mutations, four of them were homozygous (c.498insC, c.498delC, c.524T>C, and c.1143insC), and two of them were compound heterozygous (c.492delC and c.545C>T). Five of the mutations were located in exon 5 (428-641 bp of the consensus coding sequence), which led to an assumption that the tract of short peptide in this region might play a role in the etiology of eye anomalies [21]. We identified a heterozygous missense variation, c.496C>G (p.Pro166Ala), but this variation was also observed in normal controls and the clinically normal mother of the patient with the variation. Although it is less possible for the c.496C>G variation of MFRP to account for hyperopia, the recognition of this missense variation in the short tract of exon 5 in MFRP will help further the understanding of the role of this area in the function of MFRP.
###end p 31
###begin p 32
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 401 405 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 825 829 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
###xml 684 691 <span type="species:ncbi:9606">patient</span>
A silent variation (c.669G>A) presented in MFRP of two patients with high hyperopia, but none of the controls carried this change. Although the substitution did not change the encoded amino acid or splice method, it might affect the in vivo stability of the mRNA or protein folding, which is what has been observed for other silent variations in other systems [29-31]. Therefore, it is a variation in MFRP that has the potential to cause hyperopia. The missense variation, c.664C>A, resulted in a significant change at the amino acid level as evaluated by Blosum 62 (-1), and this substitution was not identified in the normal controls. Unfortunately, no other family members of this patient were available for us to perform a cosegregation analysis on this variation. More research is needed to reveal the effect of the two MFRP variations on simple high hyperopia.
###end p 32
###begin p 33
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFRP</italic>
###xml 153 161 <span type="species:ncbi:9606">patients</span>
In conclusion, five novel sequence variations of MFRP were identified in the Chinese population where two of these novel variations were only present in patients with physiologic high hyperopia. Our results imply that MFRP is not likely to play a major role in physiologic high hyperopia. Further studies are needed to clarify this point.
###end p 33
###begin title 34
Acknowledgments
###end title 34
###begin p 35
###xml 22 30 <span type="species:ncbi:9606">patients</span>
The authors thank all patients and controls for their participation. This study was supported in part by the National 863 Plan of China (Z19-01-04-02 to Q.Z.) and the National Science Fund for Distinguished Young Scholars (30725044 to Q.Z.).
###end p 35
###begin title 36
References
###end title 36
###begin article-title 37
###xml 19 24 <span type="species:ncbi:9606">human</span>
Emmetropisation in human infancy: rate of change is related to initial refractive error.
###end article-title 37
###begin article-title 38
Changes in refraction over a period of twenty years in a non-visually selected sample.
###end article-title 38
###begin article-title 39
The prevalence of refractive errors among adults in the United States, Western Europe, and Australia.
###end article-title 39
###begin article-title 40
Extreme hyperopia is the result of null mutations in MFRP, which encodes a Frizzled-related protein.
###end article-title 40
###begin article-title 41
Anterior chamber cleavage syndrome. A stepladder classification.
###end article-title 41
###begin article-title 42
Autosomal dominant nanophthalmos (NNO1) with high hyperopia and angle-closure glaucoma maps to chromosome 11.
###end article-title 42
###begin article-title 43
Classification of congenital and early onset retinitis pigmentosa.
###end article-title 43
###begin article-title 44
Ocular anomalies in fragile X syndrome.
###end article-title 44
###begin article-title 45
Down syndrome.
###end article-title 45
###begin article-title 46
Myopia. The nature versus nurture debate goes on.
###end article-title 46
###begin article-title 47
Hereditary high hypermetropia in the Faroe Islands.
###end article-title 47
###begin article-title 48
Common MFRP sequence variants are not associated with moderate to high hyperopia, isolated microphthalmia, and high myopia.
###end article-title 48
###begin article-title 49
Late-onset macular degeneration and long anterior lens zonules result from a CTRP5 gene mutation.
###end article-title 49
###begin article-title 50
Molecular cloning and characterization of MFRP, a novel gene encoding a membrane-type Frizzled-related protein.
###end article-title 50
###begin article-title 51
WNT/Frizzled signaling in eye development and disease.
###end article-title 51
###begin article-title 52
Developmental basis of nanophthalmos: MFRP Is required for both prenatal ocular growth and postnatal emmetropization.
###end article-title 52
###begin article-title 53
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
Mfrp, a gene encoding a frizzled related protein, is mutated in the mouse retinal degeneration 6.
###end article-title 53
###begin article-title 54
Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus.
###end article-title 54
###begin article-title 55
A Novel Mutation Confirms MFRP as the Gene Causing the Syndrome of Nanophthalmos-Renititis Pigmentosa-Foveoschisis-Optic Disk Drusen.
###end article-title 55
###begin article-title 56
A new autosomal recessive syndrome consisting of posterior microphthalmos, retinitis pigmentosa, foveoschisis, and optic disc drusen is caused by a MFRP gene mutation.
###end article-title 56
###begin article-title 57
The 208delG mutation in FSCN2 does not associate with retinal degeneration in Chinese individuals.
###end article-title 57
###begin article-title 58
Detection of congenital color vision defects using heteroduplex-SSCP analysis.
###end article-title 58
###begin article-title 59
Molecular analysis of CHX10 and MFRP in Chinese subjects with primary angle closure glaucoma and short axial length eyes.
###end article-title 59
###begin article-title 60
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 36 41 <span type="species:ncbi:9606">human</span>
The mouse's eye and Mfrp: not quite human.
###end article-title 60
###begin article-title 61
###xml 77 85 <span type="species:ncbi:9606">patients</span>
Mutation screen of the membrane-type frizzled-related protein (MFRP) gene in patients with inherited retinal degenerations.
###end article-title 61
###begin article-title 62
The association of membrane frizzled-related protein (MFRP) gene with acute angle-closure glaucoma - a pilot study.
###end article-title 62
###begin article-title 63
A "silent" polymorphism in the MDR1 gene changes substrate specificity.
###end article-title 63
###begin article-title 64
Genetics. SNPs, silent but not invisible.
###end article-title 64
###begin article-title 65
Evaluation of the OPTC gene in primary open angle glaucoma: functional significance of a silent change.
###end article-title 65

